NFL Legend Rob Gronkowski Invests in Medicinal CBD: 'I'm Totally Pain Free Now'

View Transcript
September 10, 2019

Rob Gronkowski, the former New England Patriots' star tight end, is now an active investor in CBD infused recovery products and is lobbying the NFL to embrace the use of medicinal cannabis.

The three-time Super Bowl champion announced last month that he invested in Abacus Health Products, the parent company of topical CBD medication producer CBDMEDIC. The company is also set to launch a new line of recovery products in partnership with Gronkowski, who passionately attests to the effectiveness of CBD from his own experience.

"I'm totally pain free now, it is unbelievable," Gronkowski told Cheddar. At the young age of 29, Gronk retired from his already decorated football career in March due to several health and chronic pain issues.

He is now publicly advocating for professional sports leagues to re-examine bans on marijuana and cannabis-based products. "I am here today to appeal to the sports governing bodies of the world to update their position on CBD, whether it's the NBA, MLB, or NFL," he said at a press conference in August.

Perry Antelman, the CEO of Abacus, said that the new Gronk-inspired line of CBD products will be tailored specifically to elite athletes and will include an array of products from protein bars to topical creams.

"It is about recovery, it is about feeling better quicker," Antelman said. "Quick recovery is going to be critical especially when you are pushing the limits."

Gronkowski, who has not ruled out a return to the professional league, added that a reversal of the NFL's stance on CBD would increase the likelihood of his pursuing a second act.

"It would up my chance big time," he said, adding that using CBD medicinally during his career "would have helped relieve the pain that I was dealing with week to week."

We use cookies and similar technologies on this site to collect identifiers, such as IP address, and cookie and device IDs as described in our Privacy Policy.